Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells

High-risk neuroblastoma (NB) remains a major therapeutic challenge despite the recent advent of disialoganglioside (GD2)-antibody treatment combined with interleukin (IL)-2 and granulocyte monocyte-colony stimulating factor (GM-CSF). Indeed, more than one third of the patients still die from this di...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordeau, Martine, Belounis, Assila, Lelaidier, Martin, Cordeiro, Paulo, Sartelet, Hervé, Herblot, Sabine, Duval, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055353/
https://www.ncbi.nlm.nih.gov/pubmed/27716850
http://dx.doi.org/10.1371/journal.pone.0164401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055353/
https://www.ncbi.nlm.nih.gov/pubmed/27716850
http://dx.doi.org/10.1371/journal.pone.0164401

Ejemplares similares